loading
前日終値:
$7.06
開ける:
$7
24時間の取引高:
38,847
Relative Volume:
0.08
時価総額:
$202.94M
収益:
$67.22M
当期純損益:
$-65.78M
株価収益率:
-2.9958
EPS:
-2.3867
ネットキャッシュフロー:
$-79.02M
1週間 パフォーマンス:
+5.95%
1か月 パフォーマンス:
-14.42%
6か月 パフォーマンス:
-67.88%
1年 パフォーマンス:
-40.42%
1日の値動き範囲:
Value
$6.98
$7.1699
1週間の範囲:
Value
$6.54
$7.17
52週間の値動き範囲:
Value
$5.85
$24.17

Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile

Name
名前
Arcturus Therapeutics Holdings Inc
Name
セクター
Healthcare (1117)
Name
電話
(858) 900-2660
Name
住所
10285 SCIENCE CENTER DRIVE, SAN DIEGO, CA
Name
職員
111
Name
Twitter
@ArcturusRx
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
ARCT's Discussions on Twitter

Compare ARCT vs VRTX, REGN, ALNY, ARGX, INSM

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ARCT icon
ARCT
Arcturus Therapeutics Holdings Inc
7.14 200.67M 67.22M -65.78M -79.02M -2.3867
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
452.38 115.58B 12.07B 3.95B 3.19B 15.33
REGN icon
REGN
Regeneron Pharmaceuticals Inc
754.66 79.23B 14.34B 4.50B 3.77B 41.56
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
329.83 43.59B 3.71B 313.75M 465.38M 2.2571
ARGX icon
ARGX
Argen X Se Adr
687.12 43.26B 4.16B 1.29B 734.26M 19.58
INSM icon
INSM
Insmed Inc
147.06 31.97B 606.42M -1.28B -997.58M -6.403

Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-03-18 開始されました B. Riley Securities Buy
2026-01-23 開始されました Roth Capital Buy
2025-10-24 ダウングレード H.C. Wainwright Buy → Neutral
2025-10-23 ダウングレード Citigroup Buy → Neutral
2025-10-22 ダウングレード Guggenheim Buy → Neutral
2025-09-04 再開されました H.C. Wainwright Buy
2025-05-28 開始されました Scotiabank Sector Outperform
2025-01-28 開始されました BTIG Research Buy
2024-08-12 開始されました Leerink Partners Outperform
2023-12-13 開始されました Canaccord Genuity Buy
2023-07-24 開始されました William Blair Outperform
2023-05-11 アップグレード H.C. Wainwright Neutral → Buy
2022-11-14 再開されました Wells Fargo Overweight
2022-11-10 ダウングレード Robert W. Baird Neutral → Underperform
2022-11-03 アップグレード Citigroup Neutral → Buy
2022-11-02 アップグレード Barclays Underweight → Equal Weight
2022-08-10 ダウングレード Raymond James Mkt Perform → Underperform
2022-07-19 再開されました Cantor Fitzgerald Overweight
2022-05-11 アップグレード Robert W. Baird Underperform → Neutral
2022-04-21 ダウングレード Citigroup Buy → Neutral
2022-01-31 アップグレード Raymond James Underperform → Mkt Perform
2021-08-12 ダウングレード Raymond James Mkt Perform → Underperform
2021-08-11 ダウングレード Goldman Neutral → Sell
2021-08-10 ダウングレード Robert W. Baird Neutral → Underperform
2021-07-02 開始されました Cantor Fitzgerald Overweight
2021-06-25 再開されました Goldman Neutral
2021-06-21 ダウングレード Barclays Equal Weight → Underweight
2021-06-04 再開されました Robert W. Baird Neutral
2021-02-17 ダウングレード B. Riley Securities Neutral → Sell
2021-01-19 ダウングレード B. Riley Securities Buy → Neutral
2021-01-15 ダウングレード B. Riley Securities Buy → Neutral
2021-01-07 開始されました Wells Fargo Overweight
2020-12-29 ダウングレード Barclays Overweight → Equal Weight
2020-12-29 ダウングレード H.C. Wainwright Buy → Neutral
2020-12-29 ダウングレード Raymond James Outperform → Mkt Perform
2020-12-29 ダウングレード Robert W. Baird Outperform → Neutral
2020-12-23 ダウングレード ROTH Capital Buy → Sell
2020-12-08 繰り返されました B. Riley Securities Buy
2020-12-07 繰り返されました B. Riley Securities Buy
2020-10-26 開始されました Barclays Overweight
2020-10-06 開始されました Citigroup Buy
2020-08-26 開始されました Piper Sandler Overweight
2020-07-30 再開されました ROTH Capital Buy
2020-07-16 開始されました Raymond James Outperform
2020-07-13 開始されました B. Riley FBR Buy
2020-06-09 ダウングレード WBB Securities Buy → Hold
2020-02-11 開始されました Robert W. Baird Outperform
2020-02-07 開始されました Guggenheim Buy
2020-02-06 開始されました Guggenheim Buy
2019-04-05 開始されました H.C. Wainwright Buy
2018-09-20 アップグレード WBB Securities Buy → Strong Buy
2018-01-22 開始されました Chardan Capital Markets Buy
すべてを表示

Arcturus Therapeutics Holdings Inc (ARCT) 最新ニュース

pulisher
Mar 24, 2026

Understanding the Setup: (ARCT) and Scalable Risk - Stock Traders Daily

Mar 24, 2026
pulisher
Mar 23, 2026

Arcturus Therapeutics Refocuses on Rare Disease mRNA Pipeline After COVID Vaccine Success at ROTH Conf - MarketBeat

Mar 23, 2026
pulisher
Mar 23, 2026

Arcturus Therapeutics at the 38th Annual Roth Conference: Strategic Shift to Rare Diseases - Investing.com Canada

Mar 23, 2026
pulisher
Mar 23, 2026

These Are the Only 3 Stocks That Cathie Wood Bought Last Week - The Motley Fool

Mar 23, 2026
pulisher
Mar 23, 2026

Arcturus Therapeutics stock plunges 50% after weak cystic fibrosis trial data - MSN

Mar 23, 2026
pulisher
Mar 23, 2026

ARCT Stock Price, Quote & Chart | ARCTURUS THERAPEUTICS HOLDIN (NASDAQ:ARCT) - ChartMill

Mar 23, 2026
pulisher
Mar 21, 2026

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2025 earnings call transcript - MSN

Mar 21, 2026
pulisher
Mar 20, 2026

This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday - Benzinga

Mar 20, 2026
pulisher
Mar 20, 2026

Arcturus Therapeutics (NASDAQ:ARCT) Stock Rating Upgraded by B. Riley Financial - MarketBeat

Mar 20, 2026
pulisher
Mar 20, 2026

This BP Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Friday - Benzinga

Mar 20, 2026
pulisher
Mar 20, 2026

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 20, 2026
pulisher
Mar 19, 2026

This Xponential Fitness Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday - Benzinga

Mar 19, 2026
pulisher
Mar 19, 2026

This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Mar 19, 2026
pulisher
Mar 19, 2026

This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday - Benzinga

Mar 19, 2026
pulisher
Mar 19, 2026

B Riley Securities initiates coverage of Arcturus Therapeutics Holdings (ARCT) with buy recommendation - MSN

Mar 19, 2026
pulisher
Mar 18, 2026

Cathie Wood’s ARK sells Guardant Health stock, buys Arcturus Therapeutics - Investing.com

Mar 18, 2026
pulisher
Mar 18, 2026

Cathie Wood’s ARK sells Guardant Health stock, buys Arcturus Therapeutics By Investing.com - Investing.com Australia

Mar 18, 2026
pulisher
Mar 18, 2026

Arcturus Therapeutics (NASDAQ:ARCT) Coverage Initiated at B. Riley Financial - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

This Evommune Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Mar 18, 2026
pulisher
Mar 18, 2026

ARCT: B. Riley Securities Initiates Coverage with 'Buy' Rating | - GuruFocus

Mar 18, 2026
pulisher
Mar 17, 2026

Arcturus Therapeutics stresses importance of phased clinical trials in drug development - Traders Union

Mar 17, 2026
pulisher
Mar 16, 2026

Update Recap: How is Arcturus Therapeutics Holdings Inc managing supply chain issuesWeekly Stock Summary & Short-Term Swing Trade Alerts - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 16, 2026

Can Arcturus Therapeutics Holdings Inc sustain its profitabilityMarket Sentiment Review & Reliable Entry Point Alerts - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 13, 2026

The Technical Signals Behind (ARCT) That Institutions Follow - Stock Traders Daily

Mar 13, 2026
pulisher
Mar 12, 2026

Arcturus Therapeutics Teases 12-Week Phase 2 CF Study After Well-Tolerated Inhaled mRNA Dosing - MarketBeat

Mar 12, 2026
pulisher
Mar 09, 2026

Patients and scientists join forces for rare disease progress, Arcturus Therapeutics asserts - Traders Union

Mar 09, 2026
pulisher
Mar 08, 2026

ARCT Should I Buy - Intellectia AI

Mar 08, 2026
pulisher
Mar 07, 2026

Arcturus (ARCT) Q4 2025 Earnings Call Transcript - AOL.com

Mar 07, 2026
pulisher
Mar 06, 2026

Stock Report: Can Arcturus Therapeutics Holdings Inc sustain its profitabilityJuly 2025 Fed Impact & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Arcturus Therapeutics: Downgrading to "Hold" As CF Program Shifts Population Focus (ARCT) - Seeking Alpha

Mar 06, 2026
pulisher
Mar 06, 2026

Arcturus Therapeutics to attend Leerink Partners 2026 Global Healthcare Conference - Traders Union

Mar 06, 2026
pulisher
Mar 06, 2026

Q1 EPS Forecast for Arcturus Therapeutics Reduced by Analyst - MarketBeat

Mar 06, 2026
pulisher
Mar 05, 2026

Demystifying Arcturus Therapeutics: Insights From 4 Analyst Reviews - Benzinga

Mar 05, 2026
pulisher
Mar 05, 2026

Citigroup Lowers Price Target for Arcturus Therapeutics (ARCT) t - GuruFocus

Mar 05, 2026
pulisher
Mar 05, 2026

Citigroup Issues Pessimistic Forecast for Arcturus Therapeutics (NASDAQ:ARCT) Stock Price - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Arcturus Therapeutics to Attend Upcoming Investor Conference - PharmiWeb.com

Mar 05, 2026
pulisher
Mar 05, 2026

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 05, 2026
pulisher
Mar 05, 2026

ARK Investment Management LLC Boosts Position in Arcturus Therapeutics Holdings Inc. $ARCT - MarketBeat

Mar 05, 2026
pulisher
Mar 05, 2026

Piper Sandler Maintains Overweight on Arcturus Therapeutics (ARCT) March 2026 - Meyka

Mar 05, 2026
pulisher
Mar 04, 2026

Gossamer Bio, Seralutinib Misses Tight Statistical Mark But Shows Heart In High-Risk Lung Disease Study - AOL.com

Mar 04, 2026
pulisher
Mar 04, 2026

Arcturus Therapeutics Holdings ARCT Q4 Revenue Slide To US$7.2 Million Tests Growth Narrative - simplywall.st

Mar 04, 2026
pulisher
Mar 04, 2026

Arcturus Therapeutics Holdings Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 04, 2026
pulisher
Mar 04, 2026

Citigroup Issues Positive Forecast for Arcturus Therapeutics (NASDAQ:ARCT) Stock Price - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Citigroup Raises Price Target for Arcturus Therapeutics (ARCT) t - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

Piper Sandler Lowers Price Target for Arcturus Therapeutics (ARC - GuruFocus

Mar 04, 2026
pulisher
Mar 04, 2026

New nasal vaccine protects lungs for months against viruses, bacteria, and allergens - AOL.com

Mar 04, 2026
pulisher
Mar 04, 2026

Piper Sandler Cuts Arcturus Therapeutics (NASDAQ:ARCT) Price Target to $25.00 - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Arcturus Therapeutics reports financial results and pipeline progress - Traders Union

Mar 04, 2026
pulisher
Mar 04, 2026

Arcturus Therapeutics Holdings Inc (ARCT) Q4 2025 Earnings Call - GuruFocus

Mar 04, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics Q4 2025 Earnings Call Transcript - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Arcturus Therapeutics Announces Fourth Quarter and Fiscal Year 2025 Financial Results and Pipeline P - PharmiWeb.com

Mar 03, 2026

Arcturus Therapeutics Holdings Inc (ARCT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$26.98
price down icon 0.99%
$47.05
price up icon 3.03%
$52.97
price up icon 3.11%
$88.06
price down icon 0.83%
ONC ONC
$272.99
price down icon 1.11%
$146.63
price up icon 6.51%
大文字化:     |  ボリューム (24 時間):